Lymph node metastasis from non-melanoma skin cancer

Abstract

The management of non-melanoma skin cancers metastatic to the neck is challenging due to variability in biological behavior and patterns of regional lymphatic spread. Metastatic non-melanoma skin cancers to the parotid and neck often behave aggressively, with a high incidence of local recurrence after treatment and reduced five-year survival outcomes. Patterns of lymphatic spread are different from those seen in mucosal squamous cell carcinoma, with higher prevalence of disease in the parotid and superficial lymphatics. These factors require that treatment is individualized to achieve optimal outcomes. Traditionally, the management of non-melanoma skin cancers metastatic to lymph nodes has involved surgical excision followed by adjuvant radiation therapy. However, novel systemic therapies are showing promising results and their role in the management of these cancers is evolving.

Keywords

Neck / non-melanoma cutaneous malignancy / skin neoplasms / lymph nodes / lymphatic metastasis

References

[1] Shah JP. Jatin shah’s head and neck surgery and oncology. 5th ed. St. Louis, MO: Elsevier Inc.; 2019.

[2] Vauterin TJ,Morgan GJ,O’Brien CJ.Patterns of lymph node spread of cutaneous squamous cell carcinoma of the head and neck.Head Neck2006;28:785-91

[3] Marks NJ.The anatomy of the lymph nodes of the parotid gland.Clin Otolaryngol Allied Sci1984;9:271-5

[4] Pisani P,Pia F.The deep parotid lymph nodes: an anatomical and oncological study.J Laryngol Otol1996;110:148-50

[5] Stonesifer CJ,Grimes JM.Immune checkpoint inhibition in non-melanoma skin cancer: a review of current evidence.Front Oncol2021;11:734354 PMCID:PMC8720968

[6] Franzen A,Lieder A.The rising incidence of parotid metastases: our experience from four decades of parotid gland surgery.Acta Otorhinolaryngol Ital2017;37:264-9 PMCID:PMC5584096

[7] Swanson MS.Diagnosis and management of merkel cell carcinoma of the head and neck: current trends and controversies.Cancers (Basel)2014;6:1256-66 PMCID:PMC4190540

[8] McLean T,Ebrahimi A.Concurrent primary and metastatic cutaneous head and neck squamous cell carcinoma: Analysis of prognostic factors.Head Neck2013;35:1144-8

[9] Schmults CD,Carter JB,Qureshi AA.Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study.JAMA Dermatol2013;149:541-7

[10] Khurana VG,O’brien CJ,Stevens GN.Parotid and neck metastases from cutaneous squamous cell carcinoma of the head and neck.Am J Surg1995;170:446-50

[11] Brantsch KD,Schönfisch B.Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study.Lancet Oncol2008;9:713-20

[12] Karia PS,Ruiz ES.Clinical and incidental perineural invasion of cutaneous squamous cell carcinoma: a systematic review and pooled analysis of outcomes data.JAMA Dermatol2017;153:781-8 PMCID:PMC5657475

[13] Rowe DE,Day CL.Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip.J Am Acad Dermatol1992;26:976-90

[14] Newlands C,Memon A,Woolford T.Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.J Laryngol Otol2016;130:S125-32 PMCID:PMC4873942

[15] Haug K,Metzler G.Prognostic impact of perineural invasion in cutaneous squamous cell carcinoma: results of a prospective study of 1399 tumors.J Invest Dermatol2020;140:1968-75

[16] Thompson AK,Prokop LJ,Baum CL.Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis.JAMA Dermatol2016;152:419-28 PMCID:PMC4833641

[17] Stratigos AJ,Dessinioti C.European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.Eur J Cancer2020;128:60-82

[18] Harris BN,Rao S,Farwell DG.Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.Otolaryngol Head Neck Surg2017;156:863-9

[19] Kearney L,Conlon P,O’Neill JP.High-risk cutaneous malignancies and immunosuppression: Challenges for the reconstructive surgeon in the renal transplant population.J Plast Reconstr Aesthet Surg2017;70:922-30

[20] Southwell KE,Eisenberg RL,Morton RP.Effect of immunocompromise on metastatic cutaneous squamous cell carcinoma in the parotid and neck.Head Neck2006;28:244-8

[21] Yilmaz M,Friedman O.Cutaneous squamous cell carcinoma of the head and neck: management of the parotid and neck.Facial Plast Surg Clin North Am2012;20:473-81

[22] Sahovaler A,Yeh DH.Outcomes of cutaneous squamous cell carcinoma in the head and neck region with regional lymph node metastasis: a systematic review and meta-analysis.JAMA Otolaryngol Head Neck Surg2019;145:352-60 PMCID:PMC6481593

[23] Porceddu SV,Poulsen MG.Postoperative concurrent chemoradiotherapy versus postoperative radiotherapy in high-risk cutaneous squamous cell carcinoma of the head and neck: the randomized phase iii trog 05.01 trial.J Clin Oncol2018;36:1275-83

[24] Ch’ng S,Allison RS.Parotid and cervical nodal status predict prognosis for patients with head and neck metastatic cutaneous squamous cell carcinoma.J Surg Oncol2008;98:101-5

[25] Robsahm TE,Veierød MB.Cutaneous squamous cell carcinoma in Norway 1963-2011: increasing incidence and stable mortality.Cancer Med2015;4:472-80 PMCID:PMC4380972

[26] Bichakjian CK,Aasi SZ.Merkel cell carcinoma, version 1.2018, NCCN clinical practice guidelines in oncology.J Natl Compr Canc Netw2018;16:742-74

[27] Deneve JL,Marzban SS.Merkel cell carcinoma of unknown primary origin.Ann Surg Oncol2012;19:2360-6 PMCID:PMC4504007

[28] Vandeven N,Makarov V.Merkel cell carcinoma patients presenting without a primary lesion have elevated markers of immunity, higher tumor mutation burden, and improved survival.Clin Cancer Res2018;24:963-71 PMCID:PMC5815931

[29] Rizzo JM,Harms KL,Brenner C.Unknown primary Merkel cell carcinoma in the immunosuppressed patient: Case series.JAAD Case Rep2021;8:19-22 PMCID:PMC7806541

[30] Pan Z,Wu X.Merkel cell carcinoma of lymph node with unknown primary has a significantly lower association with Merkel cell polyomavirus than its cutaneous counterpart.Mod Pathol2014;27:1182-92

[31] Bajetta E,Platania M.Single-institution series of early-stage Merkel cell carcinoma: long-term outcomes in 95 patients managed with surgery alone.Ann Surg Oncol2009;16:2985-93

[32] Fagan J,Ramsey ML. Basal cell cancer. Treasure Island, FL: StatPearls, 2022.

[33] Wysong A,Tang JY.Update on metastatic basal cell carcinoma: a summary of published cases from 1981 through 2011.JAMA Dermatol2013;149:615-6

[34] Morgan FC,Karia PS,Neel VA.Factors predictive of recurrence, metastasis, and death from primary basal cell carcinoma 2 cm or larger in diameter.J Am Acad Dermatol2020;83:832-8

[35] McCusker M,Dummer R.Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of disease.Eur J Cancer2014;50:774-83

[36] Nguyen-Nielsen M,Pedersen L.The incidence of metastatic basal cell carcinoma (mBCC) in Denmark, 1997-2010.Eur J Dermatol2015;25:463-8

[37] Martinez SR,Canter RJ.Rare tumors through the looking glass: an examination of malignant cutaneous adnexal tumors.Arch Dermatol2011;147:1058-62

[38] Storino A,Tawa NE Jr.Malignant cutaneous adnexal tumors and role of SLNB.J Am Coll Surg2021;232:889-98

[39] Barnes M,Murray DR,Parker D.The risk of lymph node involvement in malignant cutaneous adnexal tumors.Am Surg.2014;80:270-4

[40] Ogata D,Yoshikawa S.Treatment strategy for cutaneous apocrine carcinoma.Int J Clin Oncol2014;19:712-5

[41] Conic RRZ,Frigerio A.Incidence and outcomes of cutaneous angiosarcoma: A SEER population-based study.J Am Acad Dermatol2020;83:809-16

[42] Wollina U,Bujok V.Dermal pleomorphic sarcoma of the scalp - report of two cases.Open Access Maced J Med Sci2019;7:2982-4 PMCID:PMC6910786

[43] Tillman BN.Cutaneous Sarcomas.Otolaryngol Clin North Am2021;54:369-78

[44] Sood A,Roshan D.A critical analysis of the prognostic performance of the 8th edition American Joint Committee on Cancer staging for metastatic cutaneous squamous cell carcinoma of the head and neck.Head Neck2019;41:1591-6

[45] Moody SA,Myers EN.Squamous cell carcinoma of the external auditory canal: an evaluation of a staging system.Am J Otol.2000;21:582-8

[46] Ruiz ES,Besaw R.Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women’s Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma.JAMA Dermatol2019;155:819-25 PMCID:PMC6583833

[47] Roscher I,Vos L.Validating 4 staging systems for cutaneous squamous cell carcinoma using population-based data: a nested case-control study.JAMA Dermatol2018;154:428-34

[48] Luk PP,Veness MJ.Prognostic value of the 8th edition American Joint Commission Cancer nodal staging system for patients with head and neck cutaneous squamous cell carcinoma: A multi-institutional study.Head Neck2021;43:558-67

[49] Ebrahimi A,Low H.The American Joint Committee on Cancer staging for metastatic head and neck cutaneous squamous cell carcinoma: A multi-institutional study of within-stage heterogeneity and impact on prognostic performance.Head Neck2020;42:3235-42

[50] Amit M,Gleber-Netto FO.Inclusion of extranodal extension in the lymph node classification of cutaneous squamous cell carcinoma of the head and neck.Cancer2021;127:1238-45

[51] Sood A,Roshan D.Number of nodal metastases and prognosis in metastatic cutaneous squamous cell carcinoma of the head and neck.ANZ J Surg2019;89:863-7

[52] Lubov J,Sioufi K.Prognostic factors of head and neck cutaneous squamous cell carcinoma: a systematic review.J Otolaryngol Head Neck Surg2021;50:54 PMCID:PMC8425113

[53] Clark JR,Veness MJ.Analysis and comparison of the 7th edition American Joint Committee on Cancer (AJCC) nodal staging system for metastatic cutaneous squamous cell carcinoma of the head and neck.Ann Surg Oncol2012;19:4252-8

[54] Karia PS,Harrington DP,Qureshi AA.Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women’s Hospital tumor staging for cutaneous squamous cell carcinoma.J Clin Oncol2014;32:327-34 PMCID:PMC3897257

[55] Forest VI,Veness MJ.N1S3: a revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastases: results of 2 Australian Cancer Centers.Cancer2010;116:1298-304

[56] O’Brien CJ,McMahon JD,Lauer CS.Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland.Head Neck2002;24:417-22

[57] Oddone N,Palme CE.Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival.Cancer2009;115:1883-91

[58] Moshiri AS.Milestones in the staging, classification, and biology of Merkel cell carcinoma.J Natl Compr Canc Netw2014;12:1255-62 PMCID:PMC4161960

[59] Heppt MV,Berking C.Comparison of guidelines for the management of patients with high-risk and advanced cutaneous squamous cell carcinoma - a systematic review.J Eur Acad Dermatol Venereol2019;33 Suppl 8:25-32

[60] Givi B,Diggs BS,Gross ND.Outcome of patients treated surgically for lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.Head Neck2011;33:999-1004

[61] O’Brien CJ,McMahon JD,Lauer CS.Incidence of cervical node involvement in metastatic cutaneous malignancy involving the parotid gland.Head Neck2001;23:744-8

[62] Thom JJ,Price DL,Starkman SJ.The role of total parotidectomy for metastatic cutaneous squamous cell carcinoma and malignant melanoma.JAMA Otolaryngol Head Neck Surg2014;140:548-54

[63] Wong WK.Elective management of cervical and parotid lymph nodes in stage N0 cutaneous squamous cell carcinoma of the head and neck: a decision analysis.Eur Arch Otorhinolaryngol2014;271:3011-9

[64] Peiffer N,Myers LL.Patterns of regional metastasis in advanced stage cutaneous squamous cell carcinoma of the auricle.Otolaryngol Head Neck Surg2011;144:36-42

[65] Yoon M,Dufresne R.Localized carcinoma of the external ear is an unrecognized aggressive disease with a high propensity for local regional recurrence.Am J Surg1992;164:574-7

[66] Mazzoni A,Zanoletti E.Primary squamous cell carcinoma of the external auditory canal: surgical treatment and long-term outcomes.Acta Otorhinolaryngol Ital.2014;34:129-37 PMCID:PMC4025180

[67] Kadakia S,Gordin E,Ducic Y.The role of parotidectomy in the treatment of auricular squamous cell carcinoma.Otolaryngol Head Neck Surg2015;152:1048-52

[68] Kadakia S,Marra D.The role of elective superficial parotidectomy in the treatment of temporal region squamous cell carcinoma.Oral Maxillofac Surg2016;20:143-7

[69] Skulsky SL,McArdle O.Review of high-risk features of cutaneous squamous cell carcinoma and discrepancies between the American Joint Committee on Cancer and NCCN Clinical Practice Guidelines in Oncology.Head Neck2017;39:578-94

[70] Amit M,Mansour J.Elective neck dissection versus observation in patients with head and neck cutaneous squamous cell carcinoma.Cancer2021;127:4413-20

[71] Tremblay-Abel V,Blouin MM,Perron É.Sentinel lymph node biopsy in high-risk cutaneous squamous cell carcinoma: analysis of a large size retrospective series.Dermatol Surg2021;47:908-13

[72] Keohane SG,Budny PG.British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020.Br J Dermatol2021;184:401-14

[73] Sapijaszko M,Bourcier M,Janiszewski P.Canadian Non-melanoma Skin Cancer Guidelines CommitteeNon-melanoma skin cancer in Canada chapter 5: management of squamous cell carcinoma.J Cutan Med Surg2015;19:249-59

[74] Harwood M,Tanabe K.Metastatic basal cell carcinoma diagnosed by sentinel lymph node biopsy.J Am Acad Dermatol2005;53:475-8

[75] Picon AI,Shaha AR.Sentinel lymph node biopsy for cutaneous head and neck melanoma: mapping the parotid gland.Ann Surg Oncol2016;23:9001-9 PMCID:PMC5545803

[76] Clark J.Metastatic Cancer to the Parotid.Adv Otorhinolaryngol78:95-103

[77] Hirshoren N,McDowell LJ,Kleid S.Management of Parotid Metastatic Cutaneous Squamous Cell Carcinoma: Regional Recurrence Rates and Survival.Otolaryngol Head Neck Surg2018;159:293-9

[78] Audet N,Gullane PJ.Cutaneous metastatic squamous cell carcinoma to the parotid gland: analysis and outcome.Head Neck2004;26:727-32

[79] Ebrahimi A,Clark JR.Predicting the pattern of regional metastases from cutaneous squamous cell carcinoma of the head and neck based on location of the primary.Head Neck2010;32:1288-94

[80] Olsen KD,de Bree R,Rinaldo A.Deep lobe parotidectomy-why, when, and how?.Eur Arch Otorhinolaryngol2017;274:4073-8

[81] Cracchiolo JR.Parotidectomy for Parotid Cancer.Otolaryngol Clin North Am2016;49:415-24 PMCID:PMC4821693

[82] Veness MJ,Palme CE.Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes.Head Neck2007;29:621-31

[83] Goh RY,Fogarty GB.Cutaneous squamous cell carcinoma metastatic to parotid - analysis of prognostic factors and treatment outcome.World J Surg Oncol2012;10:117 PMCID:PMC3422189

[84] Shao A,McIvor NP.Parotid metastatic disease from cutaneous squamous cell carcinoma: prognostic role of facial nerve sacrifice, lateral temporal bone resection, immune status and P-stage.Head Neck2014;36:545-50

[85] Woods RSR,O’Sullivan JB.Management of temporal bone malignancy in treland.J Neurol Surg B Skull Base2020;81:680-5 PMCID:PMC7755512

[86] Esclamado RM.Extracapsular spread and the perineural extension of squamous cell cancer in the cervical plexus.Arch Otolaryngol Head Neck Surg1992;118:1157-8

[87] Yesensky J,Bewley A.Facial nerve sacrifice during parotidectomy for metastatic cutaneous squamous cell carcinoma.OTO Open2021;5:2473974X21996627 PMCID:PMC7917942

[88] Solares CA,Parmar P,Panizza B.Epidemiology of clinical perineural invasion in cutaneous squamous cell carcinoma of the head and neck.Otolaryngol Head Neck Surg2012;146:746-51

[89] Panizza B,Redmond M,O’Rourke P.Surgical resection for clinical perineural invasion from cutaneous squamous cell carcinoma of the head and neck.Head Neck2012;34:1622-7

[90] Warren TA,Porceddu SV.Outcomes after surgery and postoperative radiotherapy for perineural spread of head and neck cutaneous squamous cell carcinoma.Head Neck2016;38:824-31

[91] Solares CA,Panizza BJ.Surgical management of perineural spread of head and neck cancers.J Neurol Surg B Skull Base2016;77:140-9 PMCID:PMC4846420

[92] Kwok HC,Chaplin JM,Sillars HA.Quality of life after parotid and temporal bone surgery for cancer.Laryngoscope2002;112:820-33

[93] Swendseid BP,Rao NK.The underappreciated role of auriculotemporal nerve involvement in local failure following parotidectomy for cancer.Head Neck2020;42:3253-62

[94] Iwanaga J,Watanabe K.Parotid Branches of the Auriculotemporal Nerve: An Anatomical Study With Implications for Frey Syndrome.J Craniofac Surg2017;28:262-4

[95] Tansatit T,Phetudom T.Evidence suggesting that the buccal and zygomatic branches of the facial nerve May contain parasympathetic secretomotor fibers to the parotid gland by means of communications from the auriculotemporal nerve.Aesthetic Plast Surg2015;39:1010-7

[96] Lebbe C,Grob JJ.Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline.Eur J Cancer2015;51:2396-403

[97] Amin MB,Gress DM. American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging manual. 8th ed.Chicago, IL, USA: American Joint Committee on Cancer, Springer, 2017.

[98] Lee JS,Bichakjian CK.Completion lymph node dissection or radiation therapy for sentinel node metastasis in merkel cell carcinoma.Ann Surg Oncol2019;26:386-94

[99] Al-Hakami H,Al-Garni M,Al-Shareef N.Apocrine carcinoma of the scalp with neck lymph node metastasis: A case report and review of the literature.J Family Med Prim Care2019;8:3758-62 PMCID:PMC6881922

[100] Casso C, Kwhaja S, Davies S, Al-Ani Z, Saeed SR, Homer JJ. Effect of temporal bone resection on temporomandibular joint function: a quality of life study.Otolaryngol Head Neck Surg2010;142:85-9

[101] Haymerle G,Lechner W.The effect of adjuvant radiotherapy on radial forearm free flap volume after soft palate reconstruction in 13 patients.Clin Otolaryngol2018;43:742-5

[102] Rowe D.Reconstruction of the Base of Skull Defect-Lessons Learned over 25 Combined Years.J Neurol Surg B Skull Base2016;77:161-8 PMCID:PMC4846405

[103] Rosenthal EL,McGrew BM,Magnuson JS.Evolution of a paradigm for free tissue transfer reconstruction of lateral temporal bone defects.Head Neck2008;30:589-94

[104] Urban MJ,Varelas E.Hypoglossal and Masseteric Nerve Transfer for Facial Reanimation: A Systematic Review and Meta-Analysis.Facial Plast Surg Aesthet Med2022;24:10-7

[105] Herman MP,Werning JW,Morris CG.Elective neck management for squamous cell carcinoma metastatic to the parotid area lymph nodes.Eur Arch Otorhinolaryngol2016;273:3875-9

[106] Nottage MK,Hughes BG.Prospective study of definitive chemoradiation in locally or regionally advanced squamous cell carcinoma of the skin.Head Neck2017;39:679-83

[107] Wang JT,Morgan GJ,Wang AY.Predictors of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: Improved survival with the addition of adjuvant radiotherapy.Head Neck2012;34:1524-8

[108] Veness MJ,Palme CE.Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice.Laryngoscope2005;115:870-5

[109] Porceddu SV,Yom SS.Head and Neck Cancer International Group (HNCIG) Consensus Guidelines for the Delivery of Postoperative Radiation Therapy in Complex Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN).Int J Radiat Oncol Biol Phys2020;107:641-51

[110] Tanvetyanon T,McCaffrey J.Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neck.Head Neck2015;37:840-5

[111] Goyal U,Davuluri R,Yi SK.Role of Concurrent Systemic Therapy with Adjuvant Radiation Therapy for Locally Advanced Cutaneous Head and Neck Squamous Cell Carcinoma.Cureus2017;9:e1784 PMCID:PMC5736240

[112] Lavaud J,Longvert C,Funck-Brentano E.Pembrolizumab and concurrent hypo-fractionated radiotherapy for advanced non-resectable cutaneous squamous cell carcinoma.Eur J Dermatol2019;29:636-40

[113] Joseph K,Raziee H,Smylie M.PD-1 Blockade With Concurrent Radiotherapy for Locally Advanced Inoperable Cutaneous Squamous Cell Carcinoma.J Cutan Med Surg2022;26:243-8

[114] Vaidya P,Ragab O,In GK.Concurrent radiation therapy with programmed cell death protein 1 inhibition leads to a complete response in advanced cutaneous squamous cell carcinoma.JAAD Case Rep2019;5:763-6 PMCID:PMC6728732

[115] Bishop AJ,Gunn GB.Merkel cell carcinoma of the head and neck: Favorable outcomes with radiotherapy.Head Neck2016;38 Suppl 1:E452-8

[116] Strom T,Messina JL.Improved local and regional control with radiotherapy for Merkel cell carcinoma of the head and neck.Head Neck2017;39:48-55

[117] Gunaratne DA,Veness MJ.Sentinel lymph node biopsy in Merkel cell carcinoma: a 15-year institutional experience and statistical analysis of 721 reported cases.Br J Dermatol2016;174:273-81

[118] Lok B,Mutter R.Selective radiotherapy for the treatment of head and neck Merkel cell carcinoma.Cancer2012;118:3937-44 PMCID:PMC7351349

[119] Tseng YD,Liao JJ,Nghiem PT.Factors influencing radiation treatment recommendations in early-stage Merkel cell carcinoma: a survey of US-based radiation oncologists.Expert Rev Anticancer Ther2017;17:281-7

[120] Jouary T,Dreno B.Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study.Ann Oncol2012;23:1074-80

[121] Cook MM,Goff PH.Postoperative, Single-Fraction Radiation Therapy in Merkel Cell Carcinoma of the Head and Neck.Adv Radiat Oncol2020;5:1248-54 PMCID:PMC7373007

[122] Bhatia S,Iyer JG.Adjuvant radiation therapy and chemotherapy in merkel cell carcinoma: survival analyses of 6908 cases from the national cancer data base.J Natl Cancer Inst2016;108:djw042

[123] Rush Z,Lee N.Radiation therapy in the management of Merkel cell carcinoma: current perspectives.Expert Rev Dermatol2011;6:395-404 PMCID:PMC3615640

[124] Płachta I,Czarnecka AM,Szumera-Ciećkiewicz A.Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Apocrine and Eccrine Differentiation.Int J Mol Sci2021;22:5077 PMCID:PMC8151110

[125] Płachta I,Czarnecka AM,Szumera-Ciećkiewicz A.Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Follicular Differentiation.Int J Mol Sci2021;22:4759 PMCID:PMC8125718

[126] Dessinioti C,Soura E.A Practical Guide for the Follow-Up of Patients with Advanced Basal Cell Carcinoma During Treatment with Hedgehog Pathway Inhibitors.Oncologist2019;24:e755-64 PMCID:PMC6693703

[127] D’Angelo SP,Mortier L.First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study.J Immunother Cancer2021;9:e002646 PMCID:PMC8311489

[128] Topalian SL,Amin A.Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial.J Clin Oncol2020;38:2476-87 PMCID:PMC7392746

[129] Cowey CL,Espirito JL.Clinical outcomes among unresectable, locally advanced, and metastatic cutaneous squamous cell carcinoma patients treated with systemic therapy.Cancer Med2020;9:7381-7 PMCID:PMC7571823

[130] Migden MR,Schmults CD.PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.N Engl J Med2018;379:341-51

[131] Hughes BGM,Mortier L.Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial.Ann Oncol2021;32:1276-85

[132] Maubec E,Petrow P.Phase II Study of Pembrolizumab As First-Line, Single-Drug Therapy for Patients With Unresectable Cutaneous Squamous Cell Carcinomas.J Clin Oncol2020;38:3051-61

[133] Fujisawa Y,Fujimura T.Cutaneous Angiosarcoma: The Possibility of New Treatment Options Especially for Patients with Large Primary Tumor.Front Oncol2018;8:46 PMCID:PMC5840142